Miriam Cerván-Martín1, M Irene Suazo-Sánchez2, Rocío Rivera-Egea3, Nicolás Garrido4, Saturnino Luján5, Gema Romeu5, Samuel Santos-Ribeiro6, José A Castilla7, M Carmen Gonzalvo8, Ana Clavero8, F Javier Vicente9, Vicente Maldonado10, Miguel Burgos2, Francisco J Barrionuevo2, Rafael Jiménez2, Josvany Sánchez-Curbelo11, Olga López-Rodrigo11, M Fernanda Peraza11, Iris Pereira-Caetano12, Patricia I Marques13, Filipa Carvalho14, Alberto Barros14, Lluís Bassas11, Susana Seixas13, João Gonçalves15, Sara Larriba16, Alexandra M Lopes13, Rogelio J Palomino-Morales17, F David Carmona1. 1. Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. 2. Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Granada, Spain. 3. Andrology Laboratory and Sperm Bank, IVIRMA Valencia, Valencia, Spain; IVI Foundation, Health Research Institute La Fe, Valencia, Spain. 4. IVI Foundation, Health Research Institute La Fe, Valencia, Spain; Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe, Valencia, Spain. 5. Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe, Valencia, Spain. 6. IVI-RMA Lisbon, Lisbon, Portugal; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. 7. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de las Nieves, Granada, Spain; CEIFER Biobanco - NextClinics, Granada, Spain. 8. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de las Nieves, Granada, Spain. 9. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; UGC de Urología, HU Virgen de las Nieves, Granada, Spain. 10. UGC de Obstetricia y Ginecología, Complejo Hospitalario de Jaén, Jaén, Spain. 11. Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain. 12. Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal. 13. Instituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal. 14. Serviço de Genética, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. 15. Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal; ToxOmics - Centro de Toxicogenómica e Saúde Humana, Nova Medical School, Lisbon, Portugal. 16. Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. 17. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Departamento de Bioquímica y Biología Molecular I, Universidad de Granada, Granada, Spain. Electronic address: rpm@ugr.es.
Abstract
OBJECTIVE: To evaluate whether SOHLH2 intronic variation contributes to the genetic predisposition to male infertility traits, including severe oligospermia (SO) and different nonobstructive azoospermia (NOA) clinical phenotypes. DESIGN: Genetic association study. SETTING: Not applicable. PATIENT(S): Five hundred five cases (455 infertile patients diagnosed with NOA and 50 with SO) and 1,050 healthy controls from Spain and Portugal. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Genomic DNA extraction from peripheral blood mononuclear cells, genotyping of the SOHLH2 polymorphisms rs1328626 and rs6563386 using the TaqMan allelic discrimination technology, case-control association analyses using logistic regression models, and exploration of functional annotations in publicly available databases. RESULT(S): Evidence of association was observed for both rs6563386 with SO and rs1328626 with unsuccessful sperm retrieval after testicular sperm extraction (TESE-) in the context of NOA. A dominant effect of the minor alleles was suggested in both associations, either when the subset of patients with the manifestation were compared against the control group (rs6563386/SO: P=.021, odds ratio [OR] = 0.51; rs1328626/TESE-: P=.066, OR = 1.46) or against the group of patients without the manifestation (rs6563386/SO: P=.014, OR = 0.46; rs1328626/TESE-: P=.012, OR = 2.43). The haplotype tests suggested a combined effect of both polymorphisms. In silico analyses evidenced that this effect could be due to alteration of the isoform population. CONCLUSION(S): Our data suggest that intronic variation of SOHLH2 is associated with spermatogenic failure. The genetic effect is likely caused by different haplotypes of rs6563386 and rs1328626, which may predispose to SO or TESE- depending on the specific allelic combination.
OBJECTIVE: To evaluate whether SOHLH2 intronic variation contributes to the genetic predisposition to male infertility traits, including severe oligospermia (SO) and different nonobstructive azoospermia (NOA) clinical phenotypes. DESIGN: Genetic association study. SETTING: Not applicable. PATIENT(S): Five hundred five cases (455 infertilepatients diagnosed with NOA and 50 with SO) and 1,050 healthy controls from Spain and Portugal. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Genomic DNA extraction from peripheral blood mononuclear cells, genotyping of the SOHLH2 polymorphisms rs1328626 and rs6563386 using the TaqMan allelic discrimination technology, case-control association analyses using logistic regression models, and exploration of functional annotations in publicly available databases. RESULT(S): Evidence of association was observed for both rs6563386 with SO and rs1328626 with unsuccessful sperm retrieval after testicular sperm extraction (TESE-) in the context of NOA. A dominant effect of the minor alleles was suggested in both associations, either when the subset of patients with the manifestation were compared against the control group (rs6563386/SO: P=.021, odds ratio [OR] = 0.51; rs1328626/TESE-: P=.066, OR = 1.46) or against the group of patients without the manifestation (rs6563386/SO: P=.014, OR = 0.46; rs1328626/TESE-: P=.012, OR = 2.43). The haplotype tests suggested a combined effect of both polymorphisms. In silico analyses evidenced that this effect could be due to alteration of the isoform population. CONCLUSION(S): Our data suggest that intronic variation of SOHLH2 is associated with spermatogenic failure. The genetic effect is likely caused by different haplotypes of rs6563386 and rs1328626, which may predispose to SO or TESE- depending on the specific allelic combination.
Authors: Miriam Cerván-Martín; Lara Bossini-Castillo; Andrea Guzmán-Jimenez; Rocío Rivera-Egea; Nicolás Garrido; Saturnino Luján; Gema Romeu; Samuel Santos-Ribeiro; José A Castilla; M Carmen Gonzalvo; Ana Clavero; F Javier Vicente; Vicente Maldonado; Sara González-Muñoz; Inmaculada Rodríguez-Martín; Miguel Burgos; Rafael Jiménez; Maria Graça Pinto; Isabel Pereira; Joaquim Nunes; Josvany Sánchez-Curbelo; Olga López-Rodrigo; Iris Pereira-Caetano; Patricia Isabel Marques; Filipa Carvalho; Alberto Barros; Lluís Bassas; Susana Seixas; João Gonçalves; Sara Larriba; Alexandra M Lopes; F David Carmona; Rogelio J Palomino-Morales Journal: J Pers Med Date: 2022-06-04
Authors: Miriam Cerván-Martín; Lara Bossini-Castillo; Rocío Rivera-Egea; Nicolás Garrido; Saturnino Luján; Gema Romeu; Samuel Santos-Ribeiro; José A Castilla; M Carmen Gonzalvo; Ana Clavero; F Javier Vicente; Andrea Guzmán-Jiménez; Cláudia Costa; Inés Llinares-Burguet; Chiranan Khantham; Miguel Burgos; Francisco J Barrionuevo; Rafael Jiménez; Josvany Sánchez-Curbelo; Olga López-Rodrigo; M Fernanda Peraza; Iris Pereira-Caetano; Patricia I Marques; Filipa Carvalho; Alberto Barros; Lluís Bassas; Susana Seixas; João Gonçalves; Sara Larriba; Alexandra M Lopes; Rogelio J Palomino-Morales; F David Carmona Journal: J Pers Med Date: 2020-12-29
Authors: Miriam Cerván-Martín; Lara Bossini-Castillo; Andrea Guzmán-Jiménez; Rocío Rivera-Egea; Nicolás Garrido; Saturnino Lujan; Gema Romeu; Samuel Santos-Ribeiro; José Antonio Castilla; María Del Carmen Gonzalvo; Ana Clavero; Vicente Maldonado; Francisco Javier Vicente; Miguel Burgos; Rafael Jiménez; Sara González-Muñoz; Josvany Sánchez-Curbelo; Olga López-Rodrigo; Iris Pereira-Caetano; Patricia Isabel Marques; Filipa Carvalho; Alberto Barros; Lluís Bassas; Susana Seixas; João Gonçalves; Sara Larriba; Alexandra Manuel Lopes; Rogelio Jesús Palomino-Morales; Francisco David Carmona Journal: Andrology Date: 2022-07-08 Impact factor: 4.456